Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



KISNER DANIEL L Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2023 4 KISNER DANIEL L (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 25,000 options @ $0.3553, valued at $8.9k
05/31/2023 4 KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns: Granted 5,357 shares @ $0
Granted 22,500 options to buy @ $11.2, valued at $252k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 23,109 shares @ $0
Sold 40 shares @ $1.01, valued at $40.4
Granted 34,663 options to buy @ $1.01, valued at $35k
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2021 4 KISNER DANIEL L (Director) has filed a Form 4 on Histogen Inc.
Txns: Granted 20,000 options to buy @ $0.822, valued at $16.4k
08/05/2021 4 KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 5,000 shares @ $0
Granted 7,500 options to buy @ $4.44, valued at $33.3k
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/09/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/31/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2020 4 KISNER DANIEL L (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 15,000 options @ $2.94, valued at $44.1k
06/11/2020 4 KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $5.21, valued at $78.2k
05/29/2020 4 KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns: Granted 25,000 options to buy @ $4.84, valued at $121k
09/16/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2019 4 KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.
Txns: Granted 20,000 options to buy @ $0.29, valued at $5.8k
06/13/2019 4 KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $13.5, valued at $202.5k
06/11/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
05/31/2019 4 KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns: Granted 15,000 options to buy @ $4.97, valued at $74.6k
06/25/2018 4 KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.
Txns: Granted 20,000 options to buy @ $4.99, valued at $99.8k
06/07/2018 4 KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $11.3, valued at $169.5k
06/01/2018 4 KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns: Granted 15,000 options to buy @ $15.8, valued at $237k
06/26/2017 4 KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.
Txns: Granted 20,000 options to buy @ $4.96, valued at $99.2k
06/09/2017 4 KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $18.77, valued at $281.6k
06/02/2017 4 KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns: Granted 7,500 options to buy @ $5.9, valued at $44.3k
12/30/2016 4 KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.
12/30/2016 4/A KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.
12/29/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
07/20/2016 4 KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
06/24/2016 4 KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.
Txns: Granted 20,000 options to buy @ $2.13, valued at $42.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy